Selective Up-Regulation of MAPK Signaling by Aldose Reductase (AKR1B1)

被引:0
|
作者
Pal, A. [1 ]
Palla, S. [2 ]
Ruzycki, P. A. [1 ]
Reddy, B. G. [2 ]
Petrash, J. M. [1 ]
机构
[1] Univ Colorado Denver, Rocky Mt Lions Eye Inst, Ophthalmol, Aurora, CO USA
[2] Natl Inst Nutr, Biochem, Hyderabad, Telangana, India
关键词
diabetes; enzymes/enzyme inhibitors; pathobiology;
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
2624
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Role of aldo-keto reductase family 1 member B1 (AKR1B1) in the cancer process and its therapeutic potential
    Khayami, Reza
    Hashemi, Seyyed Reza
    Kerachian, Mohammad Amin
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2020, 24 (16) : 8890 - 8902
  • [32] The AKR1B1 inhibitor epalrestat suppresses the progression of cervical cancer
    Jie Ji
    Min-Xue Xu
    Tian-Yang Qian
    Sheng-Ze Zhu
    Feng Jiang
    Zhao-Xiu Liu
    Wei-Song Xu
    Juan Zhou
    Ming-Bing Xiao
    Molecular Biology Reports, 2020, 47 : 6091 - 6103
  • [33] The AKR1B1 inhibitor epalrestat suppresses the progression of cervical cancer
    Ji, Jie
    Xu, Min-Xue
    Qian, Tian-Yang
    Zhu, Sheng-Ze
    Jiang, Feng
    Liu, Zhao-Xiu
    Xu, Wei-Song
    Zhou, Juan
    Xiao, Ming-Bing
    MOLECULAR BIOLOGY REPORTS, 2020, 47 (08) : 6091 - 6103
  • [34] Opposing roles of the aldo-keto reductases AKR1B1 and AKR1B10 in colorectal cancer
    Taskoparan, Betul
    Seza, Esin Gulce
    Demirkol, Secil
    Tuncer, Sinem
    Stefek, Milan
    Gure, Ali Osmay
    Banerjee, Sreeparna
    CELLULAR ONCOLOGY, 2017, 40 (06) : 563 - 578
  • [35] Inhibitor selectivity between aldo-keto reductase superfamily members AKR1B10 and AKR1B1: Role of Trp112 (Trp111)
    Zhang, Liping
    Zhang, Hong
    Zhao, Yining
    Li, Zhe
    Chen, Shangke
    Zhai, Jing
    Chen, Yunyun
    Xie, Wei
    Wang, Zhong
    Li, Qing
    Zheng, Xuehua
    Hu, Xiaopeng
    FEBS LETTERS, 2013, 587 (22) : 3681 - 3686
  • [36] Hormonal and developmental regulation of the mouse aldose reductase-like gene akr1b7 expression in Leydig cells
    Baron, S
    Manin, M
    Aigueperse, C
    Berger, M
    Jean, C
    Veyssière, G
    Morel, L
    JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2003, 31 (01) : 71 - 81
  • [37] Overexpression and enhanced specific activity of aldoketo reductases (AKR1B1 & AKR1B10) in human breast cancers
    Reddy, K. Ashok
    Kumar, P. Uday
    Srinivasulu, M.
    Triveni, B.
    Sharada, K.
    Ismail, Ayesha
    Reddy, G. Bhanuprakash
    BREAST, 2017, 31 : 137 - 143
  • [38] Harmful body care products - An insight into a possible detoxification pathway in humans by AKR1B1 and AKR1B10
    Appel, D.
    Hintzpeter, J.
    Martin, H. J.
    Maser, E.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2018, 391 : S45 - S45
  • [39] Pivotal role of AKR1B1 in pathogenesis of colitis associated colorectal carcinogenesis
    Syamprasad, N. P.
    Rajdev, Bishal
    Jain, Siddhi
    Panda, Samir Ranjan
    Puppala, Eswara Rao
    Chaudhari, Pradip
    Vaidya, Jayathirtha Rao
    Kumar, Gangasani Jagadeesh
    Naidu, V. G. M.
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 119
  • [40] In-silico Investigations of quinine and quinidine as potential Inhibitors of AKR1B1 and AKR1B10: Functional and structural characterization
    Ejaz, Syeda Abida
    Saeed, Amna
    Birmani, Pervez Rashid
    Katubi, Khadijah Mohammedsalaeh
    Elqahtani, Zainab Mufarreh
    Al-Buriahi, M. S.
    Ujan, Rabail
    Siddique, Farhan
    Ben Ahmed, Samia
    Alrowaili, Z. A.
    PLOS ONE, 2022, 17 (10):